Hypercoagulable state in patients with Takayasu's arteritis

Thrombosis and Haemostasis

Volumn 75, Issue 5, 1996, Pages 712-716

  Akazawa, Hiroshi ^a   Ikeda, Uichi ^a   Yamamoto, Keiji ^a   Kuroda, Toshio ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN; BETA THROMBOGLOBULIN; FIBRINOPEPTIDE A; THROMBIN; THROMBOCYTE FACTOR 4; THROMBOMODULIN; VON WILLEBRAND FACTOR;

ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM INJURY; FEMALE; HUMAN; HYPERCOAGULABILITY; MALE; PATHOGENESIS; PRIORITY JOURNAL; THROMBOGENESIS;

EID: 0029929767     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650353     Document Type: Article

References (36)

1. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 1977; 93: 94-103.
2. Nasu T. Pathology of pulseless disease: A systemic study and critical review of twenty-one autopsy cases reported in Japan. Angiology 1962; 14: 225-42.
3. Uyama O, Nagatsuka K, Nakamura M, Matsumoto M, Fujisawa A, Yoneda S, Kimura K, Abe H. Plasma concentrations of 6-keto-prostaglandin F1α in patients with hypertension, cerebrovascular disease or Takayasu's arteritis. Thromb Res 1982; 25: 71-9.
4. Numano F, Shimokado K, Kishi Y, Nishiyama K, Turkoglu C, Yajima M, Numano F, Maezawa H. Changes in the plasma levels of thromboxane B2 and cyclic nucleotides in patients with Takayasu disease. Jpn Circ J 1982; 46: 16-20.
5. Numano F, Maruyama Y, Koyama T, Numano F. Antiaggregative aspirin dosage at the affected vessel wall. Angiology 1986; 37: 695-701.
6. Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: Insights gained from studies using markers of hemostatic system activation. Blood 1987; 70: 343-50.
7. Bauer KA. Laboratory markers of coagulation activation. Arch Pathol Lab Med 1993; 117: 71-7.
8. Yamamoto K, Ikeda U, Seino Y, Mito H, Fujikawa H, Sekiguchi H, Shimada K. Coagulation activity is increased in the left atrium of patients with mitral stenosis. J Am Coll Cardiol 1995; 25: 107-12.
9. Yamamoto K, Ikeda U, Furuhashi K, Irokawa M, Nakayama T, Shimada K. The coagulation system is activated in idiopathic cardiomyopathy. J Am Coll Cardiol 1995; 25: 1634-40.
10. Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol 1988; 12: 964-72.
11. Ueno A, Awane Y, Wakabayashi A, Shimizu K. Successfully operated obliterative brachiocephalic arteritis (Takayasu) associated with the elongated coarctation. Jpn Heart J 1967; 8: 538-44.
12. Ishikawa K, Matsuura S. Occlusive thromboaortopathy (Takayasu's disease) and pregnancy: clinical course and management of 33 pregnancies and deliveries. Am J Cardiol 1982; 50: 1293-1300.
13. Niewiarowski S, Thomas DP. Platelet factor 4 and adenosine diphosphate release during human platelet aggregation. Nature 1969; 222: 1269-70.
14. Moore S, Pepper DS, Cash JD. The isolation and characterisation of a platelet-specific β-globulin (β-thromboglobulin) and the detection of antiurokinase and antiplasmin released from thrombin-aggregated washed human platelets. Biochim Biophys Acta 1975; 379: 360-9.
15. Fisher M, Levine PH, Fullerton AL, Forsberg A, Duffy CP, Hoogasian JJ, Drachman DA. Marker proteins of platelet activation in patients with cerebrovascular disease. Arch Neurol 1982; 39: 692-5.
16. Nossel HL, Wasser J, Kaplan KL, LaGamma KS, Yudelman I, Canfield RE. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J Clin Invest 1979; 64: 1371-8.
17. Al-Mondhiry H. Beta-thromboglobulin and platelet-factor 4 in patients with cancer: correlation with the stage of disease and the effect of chemotherapy. Am J Hematol 1983; 14: 105-11.
18. Voisin PJ, Rousselle D, Streiff F, Debry G, Stoltz JF, Drouin P. Reduction of beta-thromboglobulin levels in diabetics controlled by artificial pancreas. Metabolism 1983; 32: 138-41.
19. Hoogendijk EMG, ten Cate JW, Ludlam CA, Bruin T. No effect of aspirin on β-thromboglobulin plasma levels in healthy volunteers. Thromb Res 1980; 19: 257-62.
20. Carrieri P, Orefice G, Indaco A. No effect of acetylsalicylic acid on β-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. Stroke 1986; 17: 1153-5.
21. Takehara K, Igarashi A, Ishibashi Y. Dipyridamole specificially decreases platelet-derived growth factor release from platelets. Pharmacology 1990; 40: 150-6.
22. Ugarte M, de Teresa E, Lorenz P, Marin MC, de Artaza M, Martin-Judez V. Intracoronary platelet activation in ischemic heart disease: effects of ticlopidine. Am Heart J 1985; 109: 738-43.
23. Berglund U, von Schenck H, Wallentin L. Effects of ticlopidine of platelet function in men with stable angina pectoris. Thromb Haemost 1985; 54: 808-12.
24. Bettelheim FR. The clotting of fibrinogen: II. Fractionation of peptide material liberated. Biochim Biophys Acta 1956; 19: 121-30.
25. 1+2 fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-97.
26. van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520-6.
27. 2-antiplasmin complex in human plasma: application to the detection of in vivo activation of the fibrinolytic system. Thromb Haemost 1986; 56: 124-7.
28. Graeff H, Hafter R. Detection and relevance of crosslinked fibrin derivatives in blood. Semin Thromb Hemost 1982; 8: 57-68.
29. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1973; 52: 2757-64.
30. Brinkhous KM, Sultzer DL, Reddick RL, Griggs TR. Elevated plasma von Willebrand factor (vWF) levels as an index of acute endothelial injury: use of a hypotonic injury model in rats. Fed Proc 1980; 39: 630 (Abstract).
31. Nusinow SR, Federici AB, Zimmerman TS, Curd JG. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum 1984; 27: 1405-10.
32. Giustolisi R, Musso R, Cacciola E, Cacciola RR, Russo M, Petralito A. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction: expression of acute phase reaction or index of vascular endothelium damage? Thromb Haemost 1984; 51: 408.
33. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982; 257: 859-4.
34. Tomura S, Nakamura Y, Deguchi F, Chida Y, Ohno Y, Kodama S, Hayashi T, Suzuki K, Marumo F. Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy. Thromb Res 1990; 58: 413-9.
35. Wada H, Ohiwa M, Kaneko T, Tamaki S, Tanigawa M, Shirakawa S, Koyama M, Hayashi T, Suzuki K. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol 1992; 39: 20-4.
36. Karmochkine M, Cacoub P, Dorent R, Piette JC, Boffa MC, Gandjbakhch I, Godeau P. Thrombomoduline et hypertension arterielle pulmonaire. Rev Méd Interne 1992; 13: S366 (Abstract).